Antibleeding drug Trasylol pulled from shelves in US
Foreign drug company Bayer AG, has pulled Trasylol from U.S. shelves. Trasylol has been used to reduce blood loss for patients undergoing by-pass surgery and avoid transfusions. The drug was pulled amid concerns that it may be linked to a higher risk of death than other drugs. So far, no major lawsuits have been filed.
The FDA announced it would review Trasylol last month after a clinical experiment was halted when the drug appeared to be linked to a higher risk of death. There was also a study published in the New England Journal of Medicine in January of last year which advised against continued use of the drug because of the risk of kidney failure, and increased risk of heart attacks, heart failure and strokes.
Click here for the full article
Bookmark: 
